Global Pharmaceutical Logistics Market 2023
Pharmaceutical logistics encompasses the comprehensive management of multiple pharmaceutical products, encompassing medications, healthcare items, medical devices, and raw materials. This intricate process involves the careful handling, transportation, and chain management of these products, with a primary focus on maintaining their integrity and safety throughout the supply chain.
To ensure the smooth and secure delivery of pharmaceutical shipments, specific equipment and storage facilities are employed, alongside harmonized handling procedures. Additionally, the success of pharmaceutical logistics heavily relies on robust collaboration and cooperation among various stakeholders within the cold chain network.
Recent data reveals promising growth prospects for the global pharmaceutical logistics market. It is projected that by the close of 2029, the market size will experience a significant rise of USD 47.7 billion, exhibiting a Compound Annual Growth Rate (CAGR) of 6.8%. This growth trajectory underscores the escalating demand for efficient and dependable pharmaceutical supply chain solutions on a global scale. The upward trend can be attributed to several factors, including population growth, expanding healthcare access, technological advancements, and the increasing complexities associated with pharmaceutical product distribution.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pharmaceutical logistics market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Market Segmentation
Type: cold chain logistics, non cold chain logistics
Therapy area: autoimmune diseases, cardiovascular diseases (CVDs), communicable diseases, diabetes, neurological disorders, oncology, pain management, respiratory diseases, others
Origin: branded-name drugs, generic drugs, over the counter (OTC)
Product: biologics, small molecule drugs
Component: transportation, warehousing, others
Region: Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, therapy area, origin, product, component, and region. The global market for pharmaceutical logistics can be segmented by type: cold chain logistics, non cold chain logistics. Cold chain logistics refers to the specialized transportation and storage of temperature-sensitive pharmaceutical products, while non-cold chain logistics encompasses a broader range of pharmaceuticals that do not require strict temperature control. In 2022, the non-cold chain logistics segment emerged as the largest contributor to the global pharmaceutical logistics market.
Pharmaceutical logistics market is further segmented by therapy area: autoimmune diseases, cardiovascular diseases (CVDs), communicable diseases, diabetes, neurological disorders, oncology, pain management, respiratory diseases, others. According to the research, the communicable diseases segment had the largest share in the global pharmaceutical logistics market. Communicable diseases present unique logistical complexities due to their contagious nature and the urgent need for effective treatment and prevention measures. Pharmaceutical logistics plays a pivotal role in ensuring the timely and secure delivery of vaccines, antiviral medications, and other essential pharmaceutical products to locations worldwide, helping to curb the spread of these diseases.
The pharmaceutical logistics market is categorized based on the origin of pharmaceutical products, which include branded-name drugs, generic drugs, and over-the-counter (OTC) medications. Each segment represents a distinct category of pharmaceutical products with different characteristics and market dynamics. In 2022, the branded-name drugs segment emerged as the dominant player in the pharmaceutical logistics market, holding the largest revenue share. Branded-name drugs are medications that are marketed and sold under a specific brand name by the pharmaceutical companies that developed them. These drugs typically undergo extensive research, development, and regulatory processes before they are introduced into the market.
In addition to the segmentation based on origin, the pharmaceutical logistics market can also be further divided based on the type of products being transported. The two main categories in this regard are biologics and small molecule drugs. Among these product segments, the small molecule drugs segment has emerged as the dominant player in the global pharmaceutical logistics market, capturing the largest share of the market. Small molecule drugs are typically characterized by their relatively simple molecular structures and chemical composition. These drugs are commonly synthesized through chemical processes and are usually administered orally or topically.
Pharmaceutical logistics market by component is categorized into: transportation, warehousing, others. The transportation segment was the largest contributor to the global pharmaceutical logistics market in 2022. Transportation plays a critical role in the pharmaceutical supply chain, encompassing the movement of pharmaceutical products from manufacturing facilities to distribution centers, pharmacies, hospitals, and ultimately to the end consumers, such as patients. It involves various modes of transportation, including road, air, sea, and rail, depending on the distance, urgency, and specific requirements of the shipments. Time-sensitive delivery is of utmost importance in the pharmaceutical industry, especially for products with short shelf lives, temperature-sensitive medications, or those needed for emergency situations. Efficient transportation ensures that pharmaceutical products reach their destinations promptly, enabling healthcare providers to meet patient demands and maintain adequate stock levels.
The pharmaceutical logistics market by region can be segmented into: Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America. According to the research, North America had the largest share in the global pharmaceutical logistics market. The region boasts a robust healthcare infrastructure, advanced pharmaceutical manufacturing capabilities, and a significant demand for pharmaceutical products. The presence of major pharmaceutical companies and research institutions in North America drives the need for efficient logistics solutions to ensure the timely and secure delivery of medications to healthcare facilities, pharmacies, and patients. Furthermore, North America has well-established regulatory frameworks governing the pharmaceutical industry, ensuring compliance with quality standards, safety regulations, and distribution protocols. Strict adherence to these regulations is crucial in the transportation and storage of pharmaceutical products, as they often require specialized handling, temperature-controlled environments, and stringent monitoring to maintain their efficacy and integrity.
Major Companies and Competitive Landscape
The report provides an in-depth analysis of the Global Pharmaceutical Logistics Market, focusing on recent developments and profiling key vendors in the industry. These key vendors include AmerisourceBergen Corporation, Bollore SE, C.H. Robinson Worldwide, Inc., CEVA Logistics Ltd., China National Medicines Corporation Ltd., CMA CGM SA, Deutsche Post DHL Group, DP World Ltd., DSV A/S, FedEx Corporation, GXO Logistics, Inc., Kuehne + Nagel International AG, Nippon Express Co., Ltd., Schenker AG, SEKO Worldwide, LLC, SF Express Co., Ltd., Singapore Post Limited, Sinotrans Limited, United Parcel Service, Inc. (UPS), Yusen Logistics Co., Ltd., among others.
The report thoroughly analyzes these key players and their strategies to provide insights into the competitive landscape of the pharmaceutical logistics market. It examines factors such as market share, revenue growth, product portfolio, geographical presence, and strategic initiatives undertaken by each vendor. This analysis aims to help stakeholders understand the positioning and competitiveness of these companies in the market.
Scope of the Report
To analyze and forecast the market size of the global pharmaceutical logistics market.
To classify and forecast the global pharmaceutical logistics market based on type, therapy area, origin, product, component, region.
To identify drivers and challenges for the global pharmaceutical logistics market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pharmaceutical logistics market.
To identify and analyze the profile of leading players operating in the global pharmaceutical logistics market.
Why Choose This Report
Gain a reliable outlook of the global pharmaceutical logistics market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
To ensure the smooth and secure delivery of pharmaceutical shipments, specific equipment and storage facilities are employed, alongside harmonized handling procedures. Additionally, the success of pharmaceutical logistics heavily relies on robust collaboration and cooperation among various stakeholders within the cold chain network.
Recent data reveals promising growth prospects for the global pharmaceutical logistics market. It is projected that by the close of 2029, the market size will experience a significant rise of USD 47.7 billion, exhibiting a Compound Annual Growth Rate (CAGR) of 6.8%. This growth trajectory underscores the escalating demand for efficient and dependable pharmaceutical supply chain solutions on a global scale. The upward trend can be attributed to several factors, including population growth, expanding healthcare access, technological advancements, and the increasing complexities associated with pharmaceutical product distribution.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global pharmaceutical logistics market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Market Segmentation
Type: cold chain logistics, non cold chain logistics
Therapy area: autoimmune diseases, cardiovascular diseases (CVDs), communicable diseases, diabetes, neurological disorders, oncology, pain management, respiratory diseases, others
Origin: branded-name drugs, generic drugs, over the counter (OTC)
Product: biologics, small molecule drugs
Component: transportation, warehousing, others
Region: Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, therapy area, origin, product, component, and region. The global market for pharmaceutical logistics can be segmented by type: cold chain logistics, non cold chain logistics. Cold chain logistics refers to the specialized transportation and storage of temperature-sensitive pharmaceutical products, while non-cold chain logistics encompasses a broader range of pharmaceuticals that do not require strict temperature control. In 2022, the non-cold chain logistics segment emerged as the largest contributor to the global pharmaceutical logistics market.
Pharmaceutical logistics market is further segmented by therapy area: autoimmune diseases, cardiovascular diseases (CVDs), communicable diseases, diabetes, neurological disorders, oncology, pain management, respiratory diseases, others. According to the research, the communicable diseases segment had the largest share in the global pharmaceutical logistics market. Communicable diseases present unique logistical complexities due to their contagious nature and the urgent need for effective treatment and prevention measures. Pharmaceutical logistics plays a pivotal role in ensuring the timely and secure delivery of vaccines, antiviral medications, and other essential pharmaceutical products to locations worldwide, helping to curb the spread of these diseases.
The pharmaceutical logistics market is categorized based on the origin of pharmaceutical products, which include branded-name drugs, generic drugs, and over-the-counter (OTC) medications. Each segment represents a distinct category of pharmaceutical products with different characteristics and market dynamics. In 2022, the branded-name drugs segment emerged as the dominant player in the pharmaceutical logistics market, holding the largest revenue share. Branded-name drugs are medications that are marketed and sold under a specific brand name by the pharmaceutical companies that developed them. These drugs typically undergo extensive research, development, and regulatory processes before they are introduced into the market.
In addition to the segmentation based on origin, the pharmaceutical logistics market can also be further divided based on the type of products being transported. The two main categories in this regard are biologics and small molecule drugs. Among these product segments, the small molecule drugs segment has emerged as the dominant player in the global pharmaceutical logistics market, capturing the largest share of the market. Small molecule drugs are typically characterized by their relatively simple molecular structures and chemical composition. These drugs are commonly synthesized through chemical processes and are usually administered orally or topically.
Pharmaceutical logistics market by component is categorized into: transportation, warehousing, others. The transportation segment was the largest contributor to the global pharmaceutical logistics market in 2022. Transportation plays a critical role in the pharmaceutical supply chain, encompassing the movement of pharmaceutical products from manufacturing facilities to distribution centers, pharmacies, hospitals, and ultimately to the end consumers, such as patients. It involves various modes of transportation, including road, air, sea, and rail, depending on the distance, urgency, and specific requirements of the shipments. Time-sensitive delivery is of utmost importance in the pharmaceutical industry, especially for products with short shelf lives, temperature-sensitive medications, or those needed for emergency situations. Efficient transportation ensures that pharmaceutical products reach their destinations promptly, enabling healthcare providers to meet patient demands and maintain adequate stock levels.
The pharmaceutical logistics market by region can be segmented into: Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America. According to the research, North America had the largest share in the global pharmaceutical logistics market. The region boasts a robust healthcare infrastructure, advanced pharmaceutical manufacturing capabilities, and a significant demand for pharmaceutical products. The presence of major pharmaceutical companies and research institutions in North America drives the need for efficient logistics solutions to ensure the timely and secure delivery of medications to healthcare facilities, pharmacies, and patients. Furthermore, North America has well-established regulatory frameworks governing the pharmaceutical industry, ensuring compliance with quality standards, safety regulations, and distribution protocols. Strict adherence to these regulations is crucial in the transportation and storage of pharmaceutical products, as they often require specialized handling, temperature-controlled environments, and stringent monitoring to maintain their efficacy and integrity.
Major Companies and Competitive Landscape
The report provides an in-depth analysis of the Global Pharmaceutical Logistics Market, focusing on recent developments and profiling key vendors in the industry. These key vendors include AmerisourceBergen Corporation, Bollore SE, C.H. Robinson Worldwide, Inc., CEVA Logistics Ltd., China National Medicines Corporation Ltd., CMA CGM SA, Deutsche Post DHL Group, DP World Ltd., DSV A/S, FedEx Corporation, GXO Logistics, Inc., Kuehne + Nagel International AG, Nippon Express Co., Ltd., Schenker AG, SEKO Worldwide, LLC, SF Express Co., Ltd., Singapore Post Limited, Sinotrans Limited, United Parcel Service, Inc. (UPS), Yusen Logistics Co., Ltd., among others.
The report thoroughly analyzes these key players and their strategies to provide insights into the competitive landscape of the pharmaceutical logistics market. It examines factors such as market share, revenue growth, product portfolio, geographical presence, and strategic initiatives undertaken by each vendor. This analysis aims to help stakeholders understand the positioning and competitiveness of these companies in the market.
Scope of the Report
To analyze and forecast the market size of the global pharmaceutical logistics market.
To classify and forecast the global pharmaceutical logistics market based on type, therapy area, origin, product, component, region.
To identify drivers and challenges for the global pharmaceutical logistics market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global pharmaceutical logistics market.
To identify and analyze the profile of leading players operating in the global pharmaceutical logistics market.
Why Choose This Report
Gain a reliable outlook of the global pharmaceutical logistics market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY TYPE
5.1 Cold chain logistics
5.2 Non cold chain logistics
PART 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA
6.1 Autoimmune diseases
6.2 Cardiovascular diseases (CVDs)
6.3 Communicable diseases
6.4 Diabetes
6.5 Neurological disorders
6.6 Oncology
6.7 Pain management
6.8 Respiratory diseases
6.9 Others
PART 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN
7.1 Branded-name drugs
7.2 Generic drugs
7.3 Over the counter (OTC)
PART 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT
8.1 Biologics
8.2 Small molecule drugs
PART 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY COMPONENT
9.1 Transportation
9.2 Warehousing
9.3 Others
PART 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY REGION
10.1 Asia-Pacific
10.2 Europe
10.3 North America
10.4 Middle East and Africa (MEA)
10.5 South America
PART 11. COMPANY PROFILES
11.1 AmerisourceBergen Corporation
11.2 Bollore SE
11.3 C.H. Robinson Worldwide, Inc.
11.4 CEVA Logistics Ltd.
11.5 China National Medicines Corporation Ltd.
11.6 CMA CGM SA
11.7 Deutsche Post DHL Group
11.8 DP World Ltd.
11.9 DSV A/S
11.10 FedEx Corporation
11.11 GXO Logistics, Inc.
11.12 Kuehne + Nagel International AG
11.13 Nippon Express Co., Ltd.
11.14 Schenker AG
11.15 SEKO Worldwide, LLC
11.16 SF Express Co., Ltd.
11.17 Singapore Post Limited
11.18 Sinotrans Limited
11.19 United Parcel Service, Inc. (UPS)
11.20 Yusen Logistics Co., Ltd.
DISCLAIMER
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY TYPE
5.1 Cold chain logistics
5.2 Non cold chain logistics
PART 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY THERAPY AREA
6.1 Autoimmune diseases
6.2 Cardiovascular diseases (CVDs)
6.3 Communicable diseases
6.4 Diabetes
6.5 Neurological disorders
6.6 Oncology
6.7 Pain management
6.8 Respiratory diseases
6.9 Others
PART 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY ORIGIN
7.1 Branded-name drugs
7.2 Generic drugs
7.3 Over the counter (OTC)
PART 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY PRODUCT
8.1 Biologics
8.2 Small molecule drugs
PART 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY COMPONENT
9.1 Transportation
9.2 Warehousing
9.3 Others
PART 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET BY REGION
10.1 Asia-Pacific
10.2 Europe
10.3 North America
10.4 Middle East and Africa (MEA)
10.5 South America
PART 11. COMPANY PROFILES
11.1 AmerisourceBergen Corporation
11.2 Bollore SE
11.3 C.H. Robinson Worldwide, Inc.
11.4 CEVA Logistics Ltd.
11.5 China National Medicines Corporation Ltd.
11.6 CMA CGM SA
11.7 Deutsche Post DHL Group
11.8 DP World Ltd.
11.9 DSV A/S
11.10 FedEx Corporation
11.11 GXO Logistics, Inc.
11.12 Kuehne + Nagel International AG
11.13 Nippon Express Co., Ltd.
11.14 Schenker AG
11.15 SEKO Worldwide, LLC
11.16 SF Express Co., Ltd.
11.17 Singapore Post Limited
11.18 Sinotrans Limited
11.19 United Parcel Service, Inc. (UPS)
11.20 Yusen Logistics Co., Ltd.
DISCLAIMER
